Cannara Biotech Inc.
LOVE.TO
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 188.13% | 63.74% | -69.18% | -18.00% | 27.20% |
| Total Depreciation and Amortization | 23.06% | -15.21% | -30.39% | 80.86% | -21.27% |
| Total Amortization of Deferred Charges | -- | 150.00% | -6.78% | -- | -- |
| Total Other Non-Cash Items | -38.83% | -51.99% | 287.40% | -27.70% | 31.58% |
| Change in Net Operating Assets | 13.07% | -1,592.05% | 96.14% | -165.15% | 173.75% |
| Cash from Operations | 90.63% | -62.09% | 176.69% | -79.16% | 654.88% |
| Capital Expenditure | -34.71% | 28.30% | -209.55% | 31.91% | -52.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 803.54% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,054.40% | 51.52% | -29.19% | 55.81% | -23.06% |
| Cash from Investing | -131.64% | 32.49% | -260.31% | 40.35% | -55.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 80.26% | -0.64% | 0.11% | 60.66% | -926.12% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -206.22% | 66.50% | 39.49% | -30.57% | 31.82% |
| Cash from Financing | -77.03% | 547.51% | 25.00% | 30.70% | -95.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.73% | 155.61% | 4,552.45% | -100.52% | 282.85% |